Publications

Filter by year

Filter by type

Filter by year

Showing all years

Disease burden, patient needs and family planning in women of childbearing age with moderate to severe psoriasis

N. da Silva-Burger, B. Stephan, N. Ganjuur, M. Augustin & R. Sommer

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

Assessing Quality of Life in Children with Dermatological Conditions – Validation of the InToDermQoL Questionnaire

J. Traxler, M. Augustin, H. Ott, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach-Renz, N. da Silva-Burger & R. Sommer

Oral presentation presented at the 23rd DKVF Conference, Potsdam, Germany

Unterdiagnostiziert und unterbehandelt

S. Schmotz, L. N. Hoyer, M. Augustin, R. Sommer, J. Traxler & S. Moritz

Certified CME training by the German Academy of Dermatology.


Dermatillomania requires specialist knowledge, a correct diagnosis and a lot of time for sensitive and differentiated exploration by the practitioner. According to current research, the treatment of choice is cognitive behavioural therapy, in particular habit reversal training.

Deutsche Dermatologie

Need for individualized counseling regarding psoriasis systemic therapy in women of childbearing age: analysis of the PsoFem study at the University Medical Center Hamburg

B. Stephan, R. Sommer, M. Augustin, N. Ganjuur & N. da Silva-Burger

For patients with moderate-to-severe psoriasis and current childbearing/ pregnancy, the choice of therapy is limited.

The present study compared the disease burden and treatment choices in women of childbearing age (WoCBA) with and without a current wish for pregnancy.

Female patients aged 18 to 45 years, with moderate-to-severe psoriasis vulgaris, were consecutively recruited. The patients reported on sociodemographic/reproductive characteristics and quality of life impairments. The physicians assessed disease severity, comorbidities, and current treatment(s). Both patients’ and dermatologists’ perceptions of shared decision-making for the current systemic treatment were surveyed.

PMID:
39555230
DOI:
https://doi.org/10.1097/JW9.0000000000000187

Effectiveness of tildrakizumab for itch, pain, and fatigue in patients with moderate-to-severe psoriasis: 52-week results from the real-world POSITIVE study

U. Mrowietz, M. Augustin, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & R. Sommer

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity

M. Böhm, R. Sommer, U. Gieler, P. Staubach, A. Zink, C. Apfelbacher & E.M.J. Peters

Vitiligo is a common disorder characterized by the visible loss of skin pigmentation. Non-segmental vitiligo (NSV) is the major subtype. The disease is caused by autoimmune-mediated destruction of melanocytes. Vitiligo leads to stigmatization and a significant reduction in quality of life. We recommend optimizing care by incorporating the assessment of quality of life as a standard in routine care, in addition to monitoring disease activity.

PMID:
39167551
DOI:
https://doi.org/10.1111/ddg.15503

Impact of patient psoriasis on partner well-being in a real-world setting: 52-week interim data of the phase IV POSITIVE study

U. Mrowietz, R. Sommer, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & M. Augustin

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

High effectiveness of tildrakizumab regardless of baseline characteristics in patients with moderate-to-severe psoriasis: 52-week results from the POSITIVE study

U. Mrowietz, R. Sommer, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & M. Augustin

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

Quality of Life in Infants and Toddlers with Dermatological Conditions – Validation of the German Version of the InToDermQoL Questionnaire

J. Traxler, N. da Silva-Burger, M. Augustin, H. Ott, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach & R. Sommer

Poster presentation presented at the 31st Annual Conference of ISOQOL, Cologne, Germany

Effectiveness of tildrakizumab in patients with moderate-to-severe psoriasis located in special areas: 52-week results from the POSITIVE study

M. Augustin, R. Sommer, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & U. Mrowietz

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

<< < 1 … 3 4 5 6 7 … 26 > >>